Dr. Edlin serves as Associate Professor of Medicine and Public Health at Weill Medical College of Cornell University and epidemiologist for the Center for the Study of Hepatitis C. His research focuses on the clinical epidemiology of hepatitis C, as well as on the epidemiology and primary and secondary prevention of viral hepatitis, HIV infection, overdose, and other infectious and non-infectious health conditions affecting drug users, exploring the effectiveness of harm reduction strategies and evaluating methods to improve their effectiveness.

An internist with training in infectious diseases and epidemiology, Dr. Edlin joined the Epidemic Intelligence Service at the Centers for Disease Control and Prevention, and served for eight years in the Division of HIV/AIDS Prevention. From 1997 through 2002, Dr. Edlin directed the Urban Health Study at the University of California, San Francisco. Dr. Edlin's work has been published in the New England Journal of Medicine, Lancet, Annals of Internal Medicine, Journal of Infectious Diseases, and many other journals. He has received numerous awards for his work, including the Donald C. Mackel Memorial Award, the Alexander D. Langmuir Award, and the Charles C. Shepard Science Award for his research on nosocomial transmission of multidrug-resistant tuberculosis. He is a fellow of the Infectious Diseases Society of America and a member of the American Association for the Study of Liver Disease, and serves on the National Institutes of Health (NIH) HIV Prevention Trials Network Scientific Working Group on Substance Use. He has served on several NIH study sections and has been the recipient of numerous research grants. Dr. Edlin was asked to address the NIH Consensus Development Conference on the Management of Hepatitis C on hepatitis C in injection drug users. The Consensus Panel adopted his recommendations, rescinding the restriction against treating drug users for hepatitis C in the new NIH guidelines, and recommending hepatitis C prevention, testing, and treatment programs for injection drug users and incarcerated persons. Dr. Edlin has been appointed to the newly formed New York State Hepatitis C Advisory Council and is a member of the Center for Substance Abuse Treatment Viral Hepatitis Treatment Consensus Panel, Substance Abuse and Mental Health Services Administration, U.S. Public Health Service.